Statewide

CvilleBioHub, a regional, industry-led organization, received a $4.3 million GO Virginia award and is partnering with UVA to establish the region's first laboratory accelerator at North Fork, a UVA Discovery Park.

CvilleBioHub, a regional, industry-led organization, received a $4.3 million GO Virginia award and is partnering with UVA to establish the region's first laboratory accelerator at North Fork, a UVA Discovery Park.

Esser will work with scientists to accelerate the development of new medicines and treatments for illnesses like cancer and Alzheimer's.

Esser will work with scientists to accelerate the development of new medicines and treatments for illnesses like cancer and Alzheimer's.

One of Esser's responsibilities will be to foster an "ecosystem of innovation" that will attract biotechnology and pharmaceutical companies to Central Virginia and the greater Commonwealth, bringing with them hundreds of jobs directly and…

One of Esser's responsibilities will be to foster an "ecosystem of innovation" that will attract biotechnology and pharmaceutical companies to Central Virginia and the greater Commonwealth, bringing with them hundreds of jobs directly and…

UVA is a member of the Virginia Alliance for Semiconductor Technology (VAST), a coalition established to elevate Virginia as a leader on the forefront of the burgeoning semiconductor industry.

UVA is a member of the Virginia Alliance for Semiconductor Technology (VAST), a coalition established to elevate Virginia as a leader on the forefront of the burgeoning semiconductor industry.

The University of Virginia and Virginia Tech are two of 21 East Coast universities partnering with semiconductor company Micron Technology Inc.

The UVA Manning Institute of Biotechnology positions UVA at the very forefront of cutting-edge medicine, such as cellular and gene therapies that revolutionize how diseases are treated and cured.

The UVA Manning Institute of Biotechnology positions UVA at the very forefront of cutting-edge medicine, such as cellular and gene therapies that revolutionize how diseases are treated and cured.

Melissa M. Lubin will lead UVA's School of Continuing and Professional Studies (SCPS) as Dean with emphasis on programs that respond to both student and workforce demand.